Loss of the PGE1 requirement for MDCK cell growth associated with a defect in cyclic AMP phosphodiesterase

J Cell Physiol. 1983 Feb;114(2):153-61. doi: 10.1002/jcp.1041140203.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • 3',5'-Cyclic-AMP Phosphodiesterases / metabolism*
  • Alprostadil
  • Animals
  • Cell Differentiation / drug effects
  • Cell Division / drug effects
  • Cell Line
  • Culture Media
  • Cyclic AMP / metabolism
  • Dogs
  • Dose-Response Relationship, Drug
  • Kidney
  • Kinetics
  • Mutation
  • Prostaglandins E / pharmacology*

Substances

  • Culture Media
  • Prostaglandins E
  • Cyclic AMP
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Alprostadil
  • 1-Methyl-3-isobutylxanthine